Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Prostate Cancer Survivors: Physical, Emotional and Practical Concerns from the LIVESTRONG survey

1. Department of Behavioral Sciences and Health Education, College of Public Health and Social Justice, Saint Louis University
2. Division of Urology, Department of Surgery, School of Medicine, Saint Louis University

Objective: To determine whether a relationship exists between types of treatment received and/or survivorship status of prostate cancer survivors with physical, emotional, and practical concerns that they experience with the hypothesis that no such relationship exists. Methods: We analyzed data from the 2010 LIVESTRONG survey for cancer survivors which queried their physical, emotional, and practical concerns. This previously tested survey was administered between June 20, 2010 and March 31, 2011 on the LIVESTRONG.org website. Survivorship status was categorized as reported by the respondents: currently on treatment; living with cancer as a chronic condition; finished treatment less than 1 year ago; 1–5 years ago and; more than 5 years ago. Four categories were established for the types of treatment received: surgery, radiation, hormonal, and combination therapies. One-way ANOVA’s were conducted to detect differences between groups and descriptive statistics were reported. Results: Of 2,307 respondents overall, only 281 males were included in this study based on self-reported primary diagnosis of prostate cancer and US residency status. The mean age of respondents was 60 years (SD = 8.54 years) and majority were white (90%). One-way ANOVA detected significant differences between the number of physical (p = 0.02), emotional (p = 0.04), and practical (p = 0.00) concerns for patients receiving different treatments. When compared across the survivorship trajectory, only number of practical concerns (p = 0.00) experienced by prostate cancer survivors were significantly different. Conclusions: Study findings highlight significant differences in number of concerns experienced by the patients based on their survivorship stage and the type of treatment received. Incorporating strategies to address the differences in physical, emotional, and practical concerns are essential to help physicians and clinical team members provide high quality post treatment survivorship care.
  Article Metrics


1. Siegel R, Ma J, Zou Z, et al. (2014) Cancer statistics, 2014. CA Cancer J Clin 64: 9-29.    

2. DeSantis CE, Lin CC, Mariotto AB, et al. (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin.

3. Bangma CH, Roemeling S, Schroder FH (2007) Overdiagnosis and overtreatment of early detected prostate cancer. World J Urol 25: 3-9.    

4. Etzioni R, Penson DF, Legler JM, et al. (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94: 981-990.

5. Hayes J, Barry MJ (2011) Preventing prostate cancer overdiagnosis from becoming overtreatment. Oncology (Williston Park) 25: 468, 471, 478.

6. Klotz L (2013) Prostate cancer overdiagnosis and overtreatment. Curr Opin Endocrinol Diabetes Obes 20: 204-209.    

7. Resnick MJ, Koyama T, Fan K-H, et al. (2013) Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer. New England Journal of Medicine 368: 436-445.    

8. Carlson LE, Angen M, Cullum J, et al. (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90: 2297-2304.

9. Punnen S, Cowan JE, Dunn LB, et al. (2013) A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int 112: E67-75.    

10. Skolarus TA, Wolf AM, Erb NL, et al. (2014) American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin.

11. Kent EE, Arora NK, Rowland JH, et al. (2012) Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Education and Counseling 89: 345-352.    

12. Watson E, Shinkins B, Frith E, et al. (2015) Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. BJU International: n/a-n/a.

13. Khan NF, Evans J, Rose PW (2011) A qualitative study of unmet needs and interactions with primary care among cancer survivors. Br J Cancer 105 Suppl 1: S46-51.

14. Bernat JK, Wittman DA, Hawley ST, et al. (2015) Symptom burden and information needs in prostate cancer survivors: a case for tailored long‐term survivorship care. BJU international.

15. Brown M (2010) Prostate cancer: how assessment of QoL can improve delivery of care. Br J Nurs 19: 1080-1084.    

16. Forsythe LP, Kent EE, Weaver KE, et al. (2013) Receipt of psychosocial care among cancer survivors in the United States. Journal of Clinical Oncology: JCO. 2012.2046. 2101.

17. Lubeck DP, Litwin MS, Henning JM, et al. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 53: 180-186.

18. Brandeis JM, Litwin MS, Burnison CM, et al. (2000) QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER. The Journal of Urology 163: 851-857.    

19. Helgason ÁR, Dickman PW, Adolfsson J, et al. (2001) Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients. Scandinavian journal of urology and nephrology 35: 97-101.    

20. Miller DC, Sanda MG, Dunn RL, et al. (2005) Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy. Journal of Clinical Oncology 23: 2772-2780.

21. Adler NE, Page AE (2008) Cancer care for the whole patient.

22. Rowland JH, Bellizzi KM (2008) Cancer survivors and survivorship research: a reflection on today's successes and tomorrow's challenges. Hematology/oncology clinics of North America 22: 181-200.    

23. Avis NE, Smith KW, McGraw S, et al. (2005) Assessing quality of life in adult cancer survivors (QLACS). Quality of life research 14: 1007-1023.    

24. Beckjord EB, Reynolds KA, Van Londen G, et al. (2014) Population-level trends in posttreatment cancer survivors’ concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys. Journal of psychosocial oncology 32: 125-151.    

25. Rechis R, Boerner L, Nutt S, et al. (2010) How cancer has affected post-treatment survivors: a LIVESTRONG report. Austin, TX: LIVESTRONG.

26. Sharifi N, Gulley JL, Dahut WL (2005) ANdrogen deprivation therapy for prostate cancer. JAMA 294: 238-244.    

27. Heidenreich A, Bastian PJ, Bellmunt J, et al. (2014) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. European urology 65: 467-479.

28. Pirl WF, Siegel GI, Goode MJ, et al. (2002) Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psycho‐Oncology 11: 518-523.    

29. Bellizzi KM, Latini DM, Cowan JE, et al. (2008) Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology 72: 1269-1273.    

30. Koch L, Jansen L, Brenner H, et al. (2013) Fear of recurrence and disease progression in long-term (>/= 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology 22: 1-11.    

31. Simard S, Thewes B, Humphris G, et al. (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. Journal of Cancer Survivorship 7: 300-322.    

32. Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho‐Oncology 22: 978-986.    

33. Rutten LJF, Arora NK, Bakos AD, et al. (2005) Information needs and sources of information among cancer patients: a systematic review of research (1980–2003). Patient education and counseling 57: 250-261.    

34. Chang S, Long SR, Kutikova L, et al. (2004) Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000. Journal of Clinical Oncology 22: 3524-3530.    

35. Timmons A, Gooberman-Hill R, Sharp L (2013) The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public–private healthcare system. Supportive Care in Cancer 21: 107-117.    

36. Penedo FJ, Dahn JR, Shen BJ, et al. (2006) Ethnicity and determinants of quality of life after prostate cancer treatment. Urology 67: 1022-1027.    

37. Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition: National Academies Press.

38. Potosky AL, Han PK, Rowland J, et al. (2011) Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26: 1403-1410.    

Copyright Info: © 2016, Prajakta Adsul, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Article outline

Show full outline
Copyright © AIMS Press All Rights Reserved